CAI
CAI
NASDAQ · Biotechnology

Caris Life Sciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$24.64
-1.39 (-5.34%)
As of Nov 7, 1:26 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 12 75%
Hold 4 25%
Sell 0 0%
Price Target
Analyst Price Target +25.5% upside
Low Target $20.23
Average Target $30.92
High Target $48.05
Current Price $24.64
Current
$24.64
Target
$30.92
$20.23 $30.92 avg $48.05
Scenario Analysis
Bear Case
$20.23
-17.9%
Low target
Base Case
$30.92
+25.5%
Avg target
Bull Case
$48.05
+95.0%
High target
Risk/Reward
5.3x
Highly favorable
Price in Context
52-Week High
$36.50
-32.5% from high
52-Week Low
$14.19
+73.6% from low
50-Day SMA
$29.48
-16.4% vs SMA
200-Day SMA
$21.67
+13.7% vs SMA
RSI (14)
36.2
Neutral
Target vs 52W High
$30.92
-15.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%